On April 28, 2017, the 12th and final participant completed the final follow-up visit and unblinding in our ongoing study of MDMA-assisted therapy for social anxiety in adults on the autism spectrum. Sponsored by MAPS, this is a collaborative study between MAPS and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, with plasma biomarker collaboration with researchers at Stanford University. Learn more…
